» Articles » PMID: 39396039

Unraveling the Roles and Mechanisms of Mitochondrial Translation in Normal and Malignant Hematopoiesis

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2024 Oct 12
PMID 39396039
Authors
Affiliations
Soon will be listed here.
Abstract

Due to spatial and genomic independence, mitochondria possess a translational mechanism distinct from that of cytoplasmic translation. Several regulators participate in the modulation of mitochondrial translation. Mitochondrial translation is coordinated with cytoplasmic translation through stress responses. Importantly, the inhibition of mitochondrial translation leads to the inhibition of cytoplasmic translation and metabolic disruption. Therefore, defects in mitochondrial translation are closely related to the functions of hematopoietic cells and various immune cells. Finally, the inhibition of mitochondrial translation is a potential therapeutic target for treating multiple hematologic malignancies. Collectively, more in-depth insights into mitochondrial translation not only facilitate our understanding of its functions in hematopoiesis, but also provide a basis for the discovery of new treatments for hematological malignancies and the modulation of immune cell function.

References
1.
Zhai X, Liu K, Fang H, Zhang Q, Gao X, Liu F . Mitochondrial C1qbp promotes differentiation of effector CD8 T cells via metabolic-epigenetic reprogramming. Sci Adv. 2021; 7(49):eabk0490. PMC: 8641941. DOI: 10.1126/sciadv.abk0490. View

2.
Richman T, Spahr H, Ermer J, Davies S, Viola H, Bates K . Loss of the RNA-binding protein TACO1 causes late-onset mitochondrial dysfunction in mice. Nat Commun. 2016; 7:11884. PMC: 4915168. DOI: 10.1038/ncomms11884. View

3.
Skrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z . Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2011; 20(5):674-88. PMC: 3221282. DOI: 10.1016/j.ccr.2011.10.015. View

4.
Park J, Choi S, Hwang S, Kim S, Choi J, Jung K . CR6-interacting factor 1 controls autoimmune arthritis by regulation of signal transducer and activator of transcription 3 pathway and T helper type 17 cells. Immunology. 2018; 156(4):413-421. PMC: 6418438. DOI: 10.1111/imm.13042. View

5.
Zhang Y, Mandava C, Cao W, Li X, Zhang D, Li N . HflX is a ribosome-splitting factor rescuing stalled ribosomes under stress conditions. Nat Struct Mol Biol. 2015; 22(11):906-13. DOI: 10.1038/nsmb.3103. View